TrialSite News

TrialSite News

Early Stage

Media and analysis to medical research

Media and analysis to medical research

Overview

Raised this Round: Raised: $59,250

Total Commitments ($USD)

Platform

PicMii

Start Date

06/07/2022

Close Date

11/30/2022

Min. Goal
$50,001
Max. Goal
$249,999
Min. Investment

$1,000

Security Type

Equity - Common

Series

Pre-Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$2.10

Pre-Money Valuation

$11,600,637

Year Founded

2021

Industry

Media, Entertainment & Publishing

Tech Sector

MediaTech

Distribution Model

B2C

Margin

Low

Capital Intensity

Low

Location

Wilmington, Delaware

Business Type

High Growth

TrialSite News, with a valuation of $11.8 million, is raising funds on PicMii. The company provides unbiased, objective, and independent media and analysis to medical research. The business publishes complex medical research for its subscribers, including physicians, healthcare professionals, patients, and investors. TrialSite News is a social and media network dedicated to medical research. The business is expected to reach 10,000 subscribers and $500,000 to $1 million in revenue by the end of 2022. Daniel O’Conner founded TrialSite News in April 2021. The current crowdfunding campaign has a minimum target of $50,001 and a maximum target of $249,998.70. The campaign proceeds will be used to add more subscribers and generate more revenues.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$256,345

$0

COGS

$0

$0

Tax

$9,751

$0

 

 

Net Income

$72,188

$0

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$116,777

$0

Accounts Receivable

$0

$0

Total Assets

$133,101

$0

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Financials as of: 06/07/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
TrialSite News on PicMii 2022
Platform: PicMii
Security Type: Equity - Common
Valuation: $11,600,637
Price per Share: $2.10

Follow company

Follow TrialSite News on PicMii 2022

Buy TrialSite News's Deal Report

Warning: according to the close date for this deal, TrialSite News may no longer be accepting investments.

TrialSite News Deal Report

Get KingsCrowd’s comprehensive report on TrialSite News including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether TrialSite News is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the TrialSite News deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge